Cited by 139Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsTGF-β signaling in diseases

Senescence‐associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15

Open access
Guo, Yuna, Ayers, Jessica L., Carter, Kelly T., Wang, Ting, Maden, Sean K., Edmond, Darwin, Newcomb P, Polly, Li, Christopher +3 more·2019·Aging Cell

Abstract

The risk of colorectal cancer (CRC) varies between people, and the cellular mechanisms mediating the differences in risk are largely unknown. Senescence has been implicated as a causative cellular mechanism for many diseases, including cancer, and may affect the risk for CRC. Senescent fibroblasts that accumulate in tissues secondary to aging and oxidative stress have been shown to promote cancer formation via a senescence‐associated secretory phenotype (SASP). In this study, we assessed the role of senescence and the SASP in CRC formation. Using primary human colon tissue, we found an accumulation of senescent fibroblasts in normal tissues from individuals with advanced adenomas or carcinomas in comparison with individuals with no polyps or CRC. In in vitro and ex vivo model systems, we induced senescence using oxidative stress in colon fibroblasts and demonstrated that the senescent fibroblasts secrete GDF15 as an essential SASP factor that promotes cell proliferation, migration, and invasion in colon adenoma and CRC cell lines as well as primary colon organoids via the MAPK and PI3K signaling pathways. In addition, we observed increased mRNA expression of GDF15 in primary normal colon tissue from people at increased risk for CRC in comparison with average risk individuals. These findings implicate the importance of a senescence‐associated tissue microenvironment and the secretory factor GDF15 in promoting CRC formation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acel.13013

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The senescence-associated tissue microenvironment promotes colon cancer formation in human colon epithelial cells and human-derived colon organoids.

    “The senescence‐associated tissue microenvironment promotes colon cancer formation in human colon epithelial cells and in human-derived colon organoids266.”

    From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [266]

    The Results section reports that senescent fibroblasts increased proliferation in colon epithelial cell lines and primary human colon organoids, and increased migration and invasion in the cell lines. It concludes that these effects *may* promote adenoma or colorectal cancer formation; the experiments described do not establish cancer formation in the cells or organoids as the citing sentence states. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Ahronian, L. G., Sennott, E. M., Van Allen, E. M., Wagle, N., Kwak, E. L., Faris, J. E., … Corcoran, R. B. (2015). Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations. Cancer Discovery, 5, 358– 367. 10.1158/2159-8290. 25673644 PMC4390490 · DOI
  2. Baek, K. E., Yoon, S. R., Kim, J.‐T., Kim, K. S., Kang, S. H., Yang, Y., … Lee, H. G. (2009). Upregulation and secretion of macrophage inhibitory cytokine‐1 (MIC‐1) in gastric cancers. Clinica Chimica Acta, 401(1–2), 128– 133. 10.1016/j.cca.2008.12.008 19133249 · DOI
  3. Bansal, N., Kumar, D., Gupta, A., Chandra, D., Sankhwar, S. N., & Mandhani, A. (2017). Relevance of MIC‐1 in the era of PSA as a serum based predictor of prostate cancer: A critical evaluation. Scientific Reports, 7(1), 16824 10.1038/s41598-017-17207-2 29203798 PMC5715056 · DOI
  4. Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., … Breit, S. N. (1997). MIC‐1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF‐beta superfamily. Proceedings of the National Academy of Sciences of the United States of America, 94(21), 11514– 11519. 9326641 PMC23523
  5. Breit, S. N., Tsai, V. W., & Brown, D. A. (2017). Targeting obesity and cachexia: Identification of the GFRAL receptor‐MIC‐1/GDF15 pathway. Trends in Molecular Medicine, 23(12), 1065– 1067. 10.1016/j.molmed.2017.10.005 29129392 · DOI
  6. Brenner, H., Hoffmeister, M., Stegmaier, C., Brenner, G., Altenhofen, L., & Haug, U. (2007). Risk of progression of advanced adenomas to colorectal cancer by age and sex: Estimates based on 840,149 screening colonoscopies. Gut, 56(11), 1585– 1589. 10.1136/gut.2007.122739 17591622 PMC2095643 · DOI
  7. Chen, J. H., Ozanne, S. E., & Hales, C. N. (2007). Methods of cellular senescence induction using oxidative stress. Methods in Molecular Biology, 371, 179– 189. 10.1007/978-1-59745-361-5_14 17634582 · DOI
  8. Coppe, J. P., Desprez, P. Y., Krtolica, A., & Campisi, J. (2010). The senescence‐associated secretory phenotype: The dark side of tumor suppression. Annual Review of Pathology: Mechanisms of Disease, 5, 99– 118. 10.1146/annurev-pathol-121808-102144 PMC4166495 20078217 · DOI · Paper page
  9. Coppede, F., Lopomo, A., Spisni, R., & Migliore, L. (2014). Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World Journal of Gastroenterology, 20(4), 943– 956. 10.3748/wjg.v20.i4.943 24574767 PMC3921546 · DOI
  10. de Jager, S. C. A., Bermúdez, B., Bot, I., Koenen, R. R., Bot, M., Kavelaars, A., … Biessen, E. A. L. (2011). Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR13‐mediated macrophage chemotaxis. Journal of Experimental Medicine, 208(2), 217– 225. 10.1084/jem.20100370 21242297 PMC3039852 · DOI
  11. Fray, M. J., & Dickinson, R. P. (2001). Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease‐3 (stromelysin‐1). Bioorganic & Medicinal Chemistry Letters, 11(4), 571– 574. 10.1016/S0960-894X(00)00720-4 11229774 · DOI
  12. Gagniere, J., Raisch, J., Veziant, J., Barnich, N., Bonnet, R., Buc, E., … Bonnet, M. (2016). Gut microbiota imbalance and colorectal cancer. World Journal of Gastroenterology, 22(2), 501– 518. 10.3748/wjg.v22.i2.501 26811603 PMC4716055 · DOI
  13. Grady, W. M., & Pritchard, C. C. (2014). Molecular alterations and biomarkers in colorectal cancer. Toxicologic Pathology, 42(1), 124– 139. 10.1177/0192623313505155 24178577 PMC3947043 · DOI
  14. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646– 674. 1016/j.cell.2011.02.013 21376230
  15. Kaur, A., Webster, M. R., Marchbank, K., Behera, R., Ndoye, A., Kugel, C. H., … Weeraratna, A. T. (2016). sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature, 532(7598), 250– 254. 10.1038/nature17392 27042933 PMC4833579 · DOI · Paper page
  16. Khalil, H., Nie, W., Edwards, R. A., & Yoo, J. (2013). Isolation of primary myofibroblasts from mouse and human colon tissue. Journal of Visualized Experiments, (80), 1– 6. 10.3791/50611 PMC3940239 24145735 · DOI
  17. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y., & Campisi, J. (2001). Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proceedings of the National Academy of Sciences of the United States of America, 98(21), 12072– 12077. 10.1073/pnas.211053698 11593017 PMC59769 · DOI · Paper page
  18. Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J., Boelens, P. G., … Watanabe, T. (2015). Colorectal cancer. Nature Reviews Disease Primers, 1, 15065 10.1038/nrdp.2015.65 PMC4874655 27189416 · DOI
  19. Lee, D. H., Yang, Y., Lee, S. J., Kim, K. Y., Koo, T. H., Shin, S. M., … Lee, J. H. (2003). Macrophage inhibitory cytokine‐1 induces the invasiveness of gastric cancer cells by up‐regulating the urokinase‐type plasminogen activator system. Cancer Research, 63(15), 4648– 4655. 12907645
  20. Li, C., Wang, J., Kong, J., Tang, J., Wu, Y., Xu, E., … Lai, M. (2016). GDF15 promotes EMT and metastasis in colorectal cancer. Oncotarget, 7(1), 860– 872. 10.18632/oncotarget.6205 26497212 PMC4808038 · DOI
  21. Mandal, P. (2017). Potential biomarkers associated with oxidative stress for risk assessment of colorectal cancer. Naunyn‐Schmiedeberg's Archives of Pharmacology, 390(6), 557– 565. 10.1007/s00210-017-1352-9 28229171 · DOI
  22. Poudel, K. R., Roh‐Johnson, M., Su, A., Ho, T., Mathsyaraja, H., Anderson, S., … Bai, J. (2018). Competition between TIAM1 and membranes balances endophilin A3 activity in cancer metastasis. Developmental Cell, 45(6), 738– 752 e736. 10.1016/j.devcel.2018.05.021 29920278 PMC6095642 · DOI
  23. Roth, P., Junker, M., Tritschler, I., Mittelbronn, M., Dombrowski, Y., Breit, S. N., … Wischhusen, J. (2010). GDF‐15 contributes to proliferation and immune escape of malignant gliomas. Clinical Cancer Research, 16(15), 3851– 3859. 10.1158/1078-0432.CCR-10-0705 20534737 · DOI
  24. Ryu, S. T., Park, B. S., Bang, H. T., Kang, H. K., & Hwangbo, J. (2016). Effects of anti‐heat diet and inverse lighting on growth performance, immune organ, microorganism and short chain fatty acids of broiler chickens under heat stress. Journal of Environmental Biology, 37(2), 185– 192. 27097436
  25. Stone, W. L., Krishnan, K., Campbell, S. E., & Palau, V. E. (2014). The role of antioxidants and pro‐oxidants in colon cancer. World Journal of Gastrointestinal Oncology, 6(3), 55– 66. 10.4251/wjgo.v6.i3.55 24653795 PMC3955779 · DOI
  26. Tsai, K. K., Chuang, E. Y., Little, J. B., & Yuan, Z. M. (2005). Cellular mechanisms for low‐dose ionizing radiation‐induced perturbation of the breast tissue microenvironment. Cancer Research, 65(15), 6734– 6744. 10.1158/0008-5472.CAN-05-0703 16061655 · DOI · Paper page
  27. Ursem, C., Atreya, C. E., & Van Loon, K. (2018). Emerging treatment options for BRAF-mutant colorectal cancer. Gastrointestinal Cancer., 8, 13– 23. 10.2147/GICTT.S125940. 29628780 PMC5889076 · DOI
  28. Val, M. M., Mendes, L. A., Alarcao, A., Carvalho, L., Carreira, I., Rodrigues, C. F., & Alpoim, M. C. (2015). Senescent bronchial fibroblasts induced to senescence by Cr(VI) promote epithelial‐mesenchymal transition when co‐cultured with bronchial epithelial cells in the presence of Cr(VI). Mutagenesis, 30(2), 277– 286. 10.1093/mutage/geu070 25406472 · DOI
  29. Wang, X., Li, Y., Tian, H., Qi, J., Li, M. O., Fu, C., … Zhang, W. (2014). Macrophage inhibitory cytokine 1 (MIC‐1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma. BMC Cancer, 14, 578 10.1186/1471-2407-14-578 25106741 PMC4133074 · DOI
  30. White, M. C., Holman, D. M., Boehm, J. E., Peipins, L. A., Grossman, M., & Henley, S. J. (2014). Age and cancer risk: A potentially modifiable relationship. American Journal of Preventive Medicine, 46(3 Suppl 1), S7– 15. 10.1016/j.amepre.2013.10.029 24512933 PMC4544764 · DOI · Paper page
  31. Yang, L., Chang, C.‐C., Sun, Z., Madsen, D., Zhu, H., Padkjær, S. B., … Jørgensen, S. B. (2017). GFRAL is the receptor for GDF15 and is required for the anti‐obesity effects of the ligand. Nature Medicine, 23(10), 1158– 1166. 10.1038/nm.4394 28846099 · DOI · Paper page

Cited by

Sorted by citations

Authors
Guo, Y., Ayers, J. L., Carter, K. T., Wang, T., Maden, S. K., Edmond, D., Newcomb P, P., Li, C., Ulrich, C., Yu, M., & Grady, W. M.
Affiliations
  • Fred Hutch Cancer Center (US)
  • University of Washington (US)
  • Public Health Sciences Division Fred Hutchinson Cancer Research Center Seattle Washington
  • Huntsman Cancer Institute (US)
Corresponding author
  • Yu, Ming
  • Grady, William M.
Venue
Aging Cell
Publisher
Wiley
Published
2019-08-06
Volume
18
Issue
6
Pages
e13013-e13013
ISSN
  • 1474-9718 (ISSN-L)
  • 1474-9726
OpenAlex
W2965836614
Cited by
139
References
16
Citations by year
2026: 24 · 2025: 32 · 2024: 17 · 2023: 12 · 2022: 21 · 2021: 16 · 2020: 16 · 2019: 1
FWCI
9.60
Type
journal article
Language
en
Open access
Locations
  • Aging Cell (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (P01CA077852, P30CA042014, P30CA15704, R01189184, R01CA194663, R01CA207371, R01CA220004, U01CA206110, U54CA143862)
  • Huntsman Cancer Foundation
  • National Cancer Institute (R50 CA233042)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
colorectal cancer, cellular senescence, senescence-associated secretory phenotype, GDF15, senescent fibroblasts, tissue microenvironment, colonic adenoma, oxidative stress, MAPK signaling, PI3K signaling, colon organoids, cancer risk, cell proliferation and invasion
MeSH terms
Aging, Cells, Cultured, Colonic Neoplasms, Fibroblasts, Humans, Phenotype, RNA, Messenger, Cellular Senescence, Growth Differentiation Factor 15, HEK293 Cells, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review